ReCode Therapeutics’ $120 Million Series B Financing

Wilson Sonsini Goodrich & Rosati represented ReCode Therapeutics in the transaction.ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of messenger…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here